Surge in biotech investments fuels overall VC gain

"Well-heeled investors poured billions into young biotech companies last year, powering overall start-up investing to its first annual increase in four years. The venture-capital investments underscore the growing interest in the emerging biomedical industry, which is creating treatments for cancer and other diseases.

The rise in overall investing also shows that the VC industry may have finally emerged from a funk that began with the 2000 tech bust, according to research out today by VentureOne and Ernst & Young."

From USATODAY.com.